Exosens
EXENS.PA · PAR
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | €2,049,078 | €832,723 | €1,066,434 | €607,747 |
| - Cash | €89,785 | €117,200 | €123,166 | €15,458 |
| + Debt | €268,443 | €261,200 | €257,446 | €316,796 |
| Enterprise Value | €2,227,736 | €976,723 | €1,200,714 | €909,085 |
| Revenue | €224,515 | €207,213 | €186,887 | €166,819 |
| % Growth | 8.3% | 10.9% | 12% | – |
| Gross Profit | €139,112 | €47,034 | €178,566 | €137,628 |
| % Margin | 62% | 22.7% | 95.5% | 82.5% |
| EBITDA | €57,512 | €45,284 | €40,319 | €61,997 |
| % Margin | 25.6% | 21.9% | 21.6% | 37.2% |
| Net Income | €27,909 | €27,836 | -€630 | €8,424 |
| % Margin | 12.4% | 13.4% | -0.3% | 5% |
| EPS Diluted | 0.55 | 0.65 | -0.045 | 0.085 |
| % Growth | -15.4% | 1,544.4% | -153.1% | – |
| Operating Cash Flow | €44,658 | €47,242 | €22,309 | €21,197 |
| Capital Expenditures | -€21,058 | -€23,000 | -€9,127 | -€15,836 |
| Free Cash Flow | €23,600 | €24,242 | €13,182 | €5,361 |